WebMar 15, 2007 · About BIOTHERANOSTICS, INC. Biotheranostics, Inc. is a provider established in San Diego, California operating as a Clinical Medical Laboratory.The NPI … WebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into 2024. The deal is expected to close in February. Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the ...
San Diego Laboratory Agrees to Pay $2 Million to Settle False …
WebApr 1, 2024 · Biotheranostics, Inc. operates a CLIA-certified and CAP-accredited diagnostic laboratory in San Diego, California. Biotheranostics, Inc., is a leading healthcare provider in the oncology field ... WebLogin. Log in. Forgot your password? Not Registered? Click here to start the process. cumberland electric tn outage map
Biotheranostics Inc. to Pay $2 Million Settlement …
WebCancerTYPE ID ® is a proprietary molecular assay using RT-PCR to measure expression of 92 genes. To classify the tumor, the gene expression profile is matched to a database of more than 2000 known tumor types and subtypes. Using this technology, CancerTYPE ID ® can identify 50 different tumor types and subtypes, covering >95% of all solid ... WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.Biotheranostics develops and markets two highly differentiated molecular … WebBiotheranostics privacy statement. This privacy statement governs your use of Biotheranostics’s website and all information you provide to Biotheranostics on our website. This Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and … east schodack ny